Call for abstracts for siRNA delivery

One of the challenges facing the broad applicability of siRNA technology is the transport of these molecules to the targeted areas of the body where they can be effective.

Merck & Co is sponsoring a symposium at the AusBiotech national conference in the hope that Australian or New Zealand scientists may be able to contribute to the resolution of the conundrum.

Merck and AusBiotech are calling for abstracts from interested parties who have expertise in the area of siRNA delivery or the delivery of nucleic acids or other such macromolecules, to present their work during AusBiotech.

Authors are requested to conform to the following guidelines for submission of abstracts:

• All abstracts and posters must be in English
• Abstracts should be submitted in MS Word, rtf or plain ASCII text
• Please indicate your preference (oral only, poster only, oral/poster)
• Abstracts should be submitted by email to gcross@ausbiotech.org
• Closing date for receipt of abstracts: Friday, August 31

For more information contact Glenn Cross, finance & business development manager on 03 9828 1400 or gcross@ausbiotech.org